Literature DB >> 14632761

Association of interleukin 1 gene family polymorphisms with duodenal ulcer disease.

M A García-González1, A Lanas, P H M Savelkoul, S Santolaria, R Benito, J B A Crusius, A S Peña.   

Abstract

Cytokine genes taking part in the immunological response to Helicobacter pylori infection are good candidates to study for genetic predisposition to duodenal ulcer disease (DU). Among cytokines, interleukin (IL)-1beta and its natural specific inhibitor, the interleukin-1 receptor antagonist, are cytokines that play a key role in regulating gastric acid secretion and modulating the immune response in the gastrointestinal mucosa. We aimed to investigate whether polymorphisms in the IL-1B and IL-1RN genes are involved in the susceptibility to duodenal ulcer. DNA from 131 unrelated Spanish Caucasian patients with DU and 105 ethnically matched healthy controls was typed for the IL-1B-511, IL-1B-31, and IL-1B + 3954 gene polymorphisms, and the VNTR polymorphism in intron 2 of the IL-1RN gene by polymerase chain reaction (PCR)-based methods and TaqMan assays. H. pylori status and non-steroidal anti-inflammatory drugs (NSAIDs) use was determined in all patients and controls. Logistic regression analysis identified H. pylori infection (OR: 9.74; 95%CI = 3.53-26.89) and NSAIDs use (OR: 8.82; 95%CI = 3.51-22.17) as independent risk factors for DU. In addition, the simultaneous carriage of IL-1RN*2, IL-1B-511*C, IL-1B-31*T and IL-1B + 3954*C alleles was a genetic risk factor for DU in patients with H. pylori infection (OR: 3.22; 95%CI = 1.09-9.47). No significant differences in IL-1RN and IL-1B genotypes were found when patients were categorized according to gender, age of onset, smoking habit, NSAIDs use, type of complication and positive family history. Our results provide further evidence that host genetic factors play a key role in the pathogenesis of duodenal ulcer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14632761      PMCID: PMC1808893          DOI: 10.1111/j.1365-2249.2003.02325.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  51 in total

1.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer.

Authors:  E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

Review 2.  H. pylori virulence factors.

Authors:  J C Atherton
Journal:  Br Med Bull       Date:  1998       Impact factor: 4.291

3.  Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis.

Authors:  N A Tountas; V Casini-Raggi; H Yang; F S Di Giovine; M Vecchi; L Kam; L Melani; T T Pizarro; J I Rotter; F Cominelli
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

4.  Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users.

Authors:  S Santolaria; A Lanas; R Benito; M f Pérez-Aisa; M Montoro; R Sainz
Journal:  Aliment Pharmacol Ther       Date:  1999-11       Impact factor: 8.171

5.  Helicobacter pylori cag pathogenicity island is associated with enhanced interleukin-8 expression in human gastric mucosa.

Authors:  B Orsini; G Ciancio; S Censini; E Surrenti; G Pellegrini; S Milani; H Herbst; A Amorosi; C Surrenti
Journal:  Dig Liver Dis       Date:  2000 Aug-Sep       Impact factor: 4.088

6.  Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis.

Authors:  O H Kantarci; E J Atkinson; D D Hebrink; C T McMurray; B G Weinshenker
Journal:  J Neuroimmunol       Date:  2000-07-01       Impact factor: 3.478

Review 7.  The role of CagA status in gastric and extragastric complications of Helicobacter pylori.

Authors:  G I Perez-Perez; R M Peek; A J Legath; P R Heine; L B Graff
Journal:  J Physiol Pharmacol       Date:  1999-12       Impact factor: 3.011

8.  Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS.

Authors:  H M Schrijver; J B Crusius; B M Uitdehaag; M A García González; P J Kostense; C H Polman; A S Peña
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

9.  Local cytokine response in Helicobacter pylori-infected subjects.

Authors:  C Lindholm; M Quiding-Järbrink; H Lönroth; A Hamlet; A M Svennerholm
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori.

Authors:  L J van Doorn; C Figueiredo; R Sanna; A Plaisier; P Schneeberger; W de Boer; W Quint
Journal:  Gastroenterology       Date:  1998-07       Impact factor: 22.682

View more
  10 in total

1.  IL-1 gene cluster and TNFA-307 polymorphisms in the risk of perforated duodenal ulcer.

Authors:  J B Guerra; G A Rocha; A M C Rocha; C M de Castro Mendes; I E B Saraiva; C A de Oliveira; D M M Queiroz
Journal:  Gut       Date:  2006-01       Impact factor: 23.059

2.  Association of specific haplotype of TNFalpha with Helicobacter pylori-mediated duodenal ulcer in eastern Indian population.

Authors:  Meenakshi Chakravorty; Dipanjana Datta De; Abhijit Choudhury; Amal Santra; Susanta Roychoudhury
Journal:  J Genet       Date:  2008-12       Impact factor: 1.166

Review 3.  To be or not to be: The host genetic factor and beyond in Helicobacter pylori mediated gastro-duodenal diseases.

Authors:  Dipanjana Datta De; Susanta Roychoudhury
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

Review 4.  Genetic polymorphisms associated with upper gastrointestinal bleeding: a systematic review.

Authors:  Marcela Forgerini; Rosa Camila Lucchetta; Gustavo Urbano; Tales Rubens de Nadai; Patrícia de Carvalho Mastroianni
Journal:  Pharmacogenomics J       Date:  2020-09-18       Impact factor: 3.550

5.  Association of IL1B -511C/-31T haplotype and Helicobacter pylori vacA genotypes with gastric ulcer and chronic gastritis.

Authors:  Dinorah N Martínez-Carrillo; Elvira Garza-González; Reyes Betancourt-Linares; Trinidad Mónico-Manzano; Cuauhtémoc Antúnez-Rivera; Adolfo Román-Román; Eugenia Flores-Alfaro; Berenice Illades-Aguiar; Gloria Fernández-Tilapa
Journal:  BMC Gastroenterol       Date:  2010-10-27       Impact factor: 3.067

6.  Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation.

Authors:  Helen Kim; Pirro G Hysi; Ludmila Pawlikowska; Annie Poon; Esteban González Burchard; Jonathan G Zaroff; Stephen Sidney; Nerissa U Ko; Achal S Achrol; Michael T Lawton; Charles E McCulloch; Pui-Yan Kwok; William L Young
Journal:  Cerebrovasc Dis       Date:  2008-12-18       Impact factor: 2.762

7.  Interleukin-1 beta single-nucleotide polymorphism's C allele is associated with elevated risk of gastric cancer in Helicobacter pylori-infected Peruvians.

Authors:  Sebastian Gehmert; Billie Velapatiño; Phabiola Herrera; Jaqueline Balqui; Livia Santivañez; Jaime Cok; Gloria Vargas; Juan Combe; Douglas J Passaro; Sijin Wen; Frank Meyer; Douglas E Berg; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2009-11       Impact factor: 2.345

Review 8.  Challenges of deciphering gastric cancer heterogeneity.

Authors:  Petra Hudler
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

9.  Immune reactions against elongation factor 2 kinase: specific pathogenesis of gastric ulcer from Helicobacter pylori infection.

Authors:  Kiyoshi Ayada; Kenji Yokota; Yoshiro Kawahara; Yumiko Yamamoto; Kazuyuki Hirai; Tomoki Inaba; Masahide Kita; Hiroyuki Okada; Kazuhide Yamamoto; Keiji Oguma
Journal:  Clin Dev Immunol       Date:  2009-07-14

10.  Functionally significant polymorphisms of the MMP-9 gene are associated with peptic ulcer disease in the Caucasian population of Central Russia.

Authors:  Oksana Minyaylo; Irina Ponomarenko; Evgeny Reshetnikov; Volodymyr Dvornyk; Mikhail Churnosov
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.